Therapeutic options for the treatment of interstitial lung diseases in systemic rheumatic diseases – systemic sclerosis as an example
نویسندگان
چکیده
منابع مشابه
Therapeutic options for systemic sclerosis.
Systemic sclerosis is a uncommon connective tissue disorder characterized by vascular damage, immune cell activation and fibrogenesis. Each of these components may respond to different therapies. Therefore, a combination strategy treating all three processes is more likely to control the disease than single agent therapy. Clinical trials have gone a long way towards defining the therapy of scle...
متن کاملThe dermal barrier in systemic sclerosis and other rheumatic diseases.
Hyaluronidase has been shown to increase the rate of spread of intradermally injected solutions in animals (Chain and Duthie, 1939, 1940) and the whole subject of spreading factors was reviewed by Duran-Reynals (1942). Holborow and Keech (1951) studied the effects of hyaluronidase in accelerating the rate of spread of a solution of haemoglobin injected intradermally in normal human subjects and...
متن کاملGuidelines for the use of systemic drugs in the treatment of skin diseases
Systemic drugs are used in the treatment of several skin diseases. In order to obtain best therapeutic results and prevent side effects, the patients should be carefully screened before and thoroughly evaluated during treatment. In this article guidelines for selection and follow up of patients receiving systemic drugs for their skin diseases are presented. These drugs include azathioprine, ant...
متن کاملMicroRNAs in systemic rheumatic diseases
MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded RNAs about 21 nucleotides in length. miRNAs have been shown to regulate gene expression and thus influence a wide range of physiological and pathological processes. Moreover, they are detected in a variety of sources, including tissues, serum, and other body fluids, such as saliva. The role of miRNAs is evident in various malignant ...
متن کاملCardiovascular Imaging Techniques in Systemic Rheumatic Diseases
The risk of cardiovascular (CV) events and mortality is significantly higher in patients with systemic rheumatic diseases than in the general population. Although CV involvement in such patients is highly heterogeneous and may affect various structures of the heart, it can now be diagnosed earlier and promptly treated. Various types of assessments are employed for the evaluation of CV risk such...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Lijec?nic?ki vjesnik
سال: 2022
ISSN: ['0024-3477', '1849-2177']
DOI: https://doi.org/10.26800/lv-144-3-4-8